Julie O'Neill - EVP. Global Operations, Alexion Pharmaceuticals Inc

As of March 2, 2018


Julie O'Neill Net Worth

  • Net worth is estimated to be at least $11.09M
  • Owns at least 42,787 units of Alexion Pharmaceuticals Inc stock
  • Sold an estimated value of $5.95M in the last 3 years at Alexion Pharmaceuticals Inc

Julie O'Neill Trading

  • Largest sale of shares was 11,160 units , worth over $1.56M on August 30, 2017
  • In total has made about 17 transactions over 3 years
  • Usually trades in March, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Julie O'Neill Mailing Address

  • Mailing address is C/o Alexion Pharmaceuticals 352 Knotter Drive Cheshire CT 06410 CT

Alexion Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Ludwig Hantson 2019 $1,250,000 - $15,243,634 - $2,430,000 $24,350 $18,947,984
Ludwig Hantson 2018 $1,200,000 - $12,385,168 - $2,880,000 $25,082 $16,490,250
Ludwig Hantson 2017 $900,000 - $9,618,758 $2,282,881 $2,275,000 $233,428 $15,310,067
Aradhana Sarin 2019 $651,764 - $3,380,763 - $813,011 $31,604 $4,877,142
Paul Clancy 2019 $927,000 - $3,863,694 - $1,051,218 $23,832 $5,865,744
Paul Clancy 2018 $900,000 - $3,302,761 - $1,260,000 $23,752 $5,486,513
Paul Clancy 2017 $415,385 $500,000 $8,799,954 $1,220,082 $473,620 $2,262 $11,411,303
Brian Goff 2019 $740,000 - $3,863,694 - $923,076 $20,240 $5,547,010
Brian Goff 2018 $695,250 - $3,096,323 - $973,350 $111,873 $4,876,796
Brian Goff 2017 $381,634 $100,000 $2,390,026 $732,899 $434,380 $58,787 $4,097,726
Anne-Marie Law 2019 $695,000 - $3,622,303 - $788,130 $33,528 $5,138,961
Anne-Marie Law 2018 $650,000 - $2,889,885 - $910,000 $846,604 $5,296,489
Anne-Marie Law 2017 $362,500 $200,000 $2,300,015 - $410,472 $68,710 $3,341,697
John Orloff 2019 $770,000 - $3,863,694 - $960,498 $32,550 $5,626,742
John Orloff 2018 $695,250 - $3,096,323 - $973,350 $98,679 $4,863,602
John Orloff 2017 $376,442 $200,000 $2,499,995 - $472,500 $80,351 $3,629,288
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/899866/000089986620000032/a2020proxy.htm

Alexion Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 24,066 units sold on December 21, 2020 by Daniel Bazarko worth over $3.8M
  • In the last 17 years, insiders at Alexion Pharmaceuticals Inc sold an estimated value of $1.09B and bought an estimated value of $426.64M
  • The most active traders are Leonard Bell, Director,  Stephen Squinto, EVP,  and Vikas Sinha, EVP & CFO
  • Insider trading is most common in February, with the busiest year in 2014

ALEXION PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1